Even though this man’s PSA level was normal, an MRI scan showed a spot in his prostate that looked like cancer — but it turned out to be a harmless nerve tumor.
Scientific Claim
A 65-year-old man with neurofibromatosis type 2 and normal prostate-specific antigen (2.07 ng/mL) had three pelvic schwannomas, including one with a PIRADS 4 score in the prostate, indicating a high suspicion for prostate cancer on imaging.
Original Statement
“The prostate-specific antigen was within the normal range (2.07 ng/ml)... The patient subsequently underwent pelvic MRI, which showed... a nodular mass measuring 12 mm in the left prostate lobe with a Prostate Imaging Reporting And Data System (PIRADS) score 4...”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim reports a specific observation: a PIRADS 4 lesion confirmed as schwannoma in one patient. No generalization about PIRADS accuracy is made.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Retrospective Cohort StudyLevel 2bThe prevalence of benign tumors mimicking PIRADS 4 lesions in patients with neurofibromatosis type 2.
The prevalence of benign tumors mimicking PIRADS 4 lesions in patients with neurofibromatosis type 2.
What This Would Prove
The prevalence of benign tumors mimicking PIRADS 4 lesions in patients with neurofibromatosis type 2.
Ideal Study Design
A multicenter retrospective cohort of 150+ NF2 patients with prostate lesions and PIRADS scores, reviewed for histopathological confirmation and comparison of MRI features between schwannomas and adenocarcinomas.
Limitation: Cannot determine if PIRADS scoring should be modified for NF2 patients.
Cross-Sectional Imaging StudyLevel 3The MRI characteristics distinguishing schwannoma from prostate cancer in PIRADS 4 lesions.
The MRI characteristics distinguishing schwannoma from prostate cancer in PIRADS 4 lesions.
What This Would Prove
The MRI characteristics distinguishing schwannoma from prostate cancer in PIRADS 4 lesions.
Ideal Study Design
A cross-sectional imaging study of 50 patients with PIRADS 4 lesions and confirmed histology (25 schwannoma, 25 adenocarcinoma), analyzing ADC values, enhancement patterns, and margins on 3T MRI.
Limitation: Cannot predict outcomes or guide treatment.
Evidence from Studies
Supporting (1)
A man with a rare nerve tumor condition had a prostate spot that looked like cancer on a scan, but doctors found out it was actually a harmless nerve tumor — not cancer — proving that even scary scans aren’t always cancer.